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Abstract 
 
The human gut is populated with hundreds of types of bacteria and fungi. In North 
America, both intestinal and mood disorders are prevalent, presenting health problems that 
challenge health care professionals and patients alike. A scholarly literature review was 
conducted to explore this important relationship.  
The investigation of the literature revealed that there is an association between gut health 
disorders and mood disorders, mainly anxiety and depression. This is due to bi-directionality 
between the brain-gut pathways, meaning that gastrointestinal health may have an effect on 
mental health and vice versa.  
This connection between gut and mood can have substantial implications for the 
treatment of both GI and mental health patients. Probiotics, bacteria that are beneficial to the 
body, have grown in popularity as a gut health supplement and may have an effect on the brain. 
Studies were conducted to test whether specific gut flora have effects on mood.  
There were many differences identified between the gut flora of those with and without 
major depressive disorder. Specific bacterium, such as Lactobacillus plantarum P8, 
Bifidobacterium longum NCC300, and Lactobacillus rhamnosus HN001; have undergone 
randomized, double-blind, placebo-controlled trials and have been found to decrease feelings of 
depression as well as anxiety. Different probiotic strains have different effects on the mind, and 
these findings may be among the newest avenues of prevention and/or treatment for depression 
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Introduction 
Have you or has someone you’ve known suffered from depression and anxiety? Chances 
are, we all know someone who has had their life affected by these disorders; and we have all 
experienced these feelings on some level. What if the key to unlocking these problems lied 
within every one of us -- inside of our gut? The research topic being explored within this paper is 
the relationship between gut health and mood disorders. The question of interest is: Does the use 
of probiotic supplementation have an effect on feelings of depression?  
The connection between gut health and mental health should be of great significance as 
approximately 6.7% of adults in the United States suffer from major depressive disorder 
(ADAA, 2018). There has been an observed association between gut health disorders and mood 
disorders, mainly anxiety and depression, with a higher prevalence in subjects with inflammatory 
bowel diseases (IBD) compared to subjects without IBD. At the same time, those who 
demonstrate anxiety and depression have an increased likelihood of developing abnormal 
gastrointestinal (GI) symptoms. This raises the possibility of bi-directionality between the brain 
and the gut, meaning that GI health may have an effect on mental health and vice versa. Due to 
the prevalence of both of these issues in North America, this relationship is important to explore 
as it can have large implications for the treatment of both GI and mental health patients. For 
example, adding psychological therapies to the treatment regime of those with IBD may lower 
their risk of disease relapse and reduce need for pharmacological treatment. Probiotics, bacteria 
that are beneficial to the body, have grown in popularity as a gut health supplement which may 
have an effect on the brain. There is much reason to suspect and explore the relationship between 
probiotic supplements and depression. 
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Literature Review 
The objective of this research was to find evidence that supports the existence of brain-
gut bidirectionality, and evidence that supplementing probiotics has an effect on the brain and 
feelings of depression. This review of literature was compiled using multiple peer-reviewed 
journals found through the Dominican University of California library databases, including 
ScienceDirect and CINAHL. Eight articles were selected to give a holistic view of the brain-gut 
pathway and how probiotics affect the brain. The literature review will be divided into three 
categories. First, articles that discuss the pathway between the brain and gut. Second, articles that 
assess gut flora and how it affects mood. And third, articles in which probiotics are tested to 
determine their effects on mental function. Study designs and methods vary between the articles 
and will be described throughout the literature review. See the Literature Review Table in 
Appendix A for a summary of each article 
The Brain-Gut Pathway 
 The articles chosen for this portion of the literature review contain data that support the 
existence of the brain-gut pathway. Gracie, Guthrie, Hamlin, and Ford (2018) are credited IBD 
researchers that wanted to answer the question: do mood disorders increase signs and symptoms 
of inflammatory bowel disease and vice versa? These researchers conducted a longitudinal study 
of 405 patients diagnosed with inflammatory bowel disease or ulcerative colitis. Data was 
collected at baseline and again after two years. This included IBD diagnosis, symptoms, 
somatization, fecal calprotectin levels (indicative of IBD flare ups), anxiety and depression data, 
and hospitalizations for IBD. The researchers used many standardized scales to compare their 
data to a control without IBD; and analysis revealed that the brain-gut pathway did, in fact, exist. 
Although the study contained a low prevalence of depression, results showed that anxiety was 
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associated with the later development of IBD flare-ups; and patients who were diagnosed with 
IBD with no anxiety at baseline showed abnormal anxiety later in the study. This was one of the 
first studies to prove that the brain and gut interact bidirectionally, and was the inspiration for 
this research paper. 
 The research team led by Kappelman, Long, Martin, Kinneer, and Chen (2013) used an 
incredibly large cohort of patients with inflammatory bowel disease to analyze and evaluate the 
association between patient-reported outcomes and disease activity. In 2014, this team recruited 
10,634 individuals through the Crohn's and Colitis Foundation of America. They performed a 
cross-sectional, longitudinal analysis of disease activity indices, patient recorded outcomes, and 
disease-specific quality of life instruments. These researchers used the Patient Reported Outcome 
Measurement Information System (PROMIS) to compare the data from IBD patients with the 
general population. They used other standardized scales such as the Simple Clinical Colitis 
Activity Index and the Short IBD Questionnaire to track disease activity for each specific type of 
IBD. Compared to the general population, patients with IBD reported more depression, anxiety, 
sleep disturbance, and social interaction. All six of the PROMIS domains indicated that 
functioning became worse as disease activity increased, and became better as disease activity 
decreased. Although this study was specific to IBD patients, the use of such a large sample size 
greatly increases the credibility and reliability of the study, making the results more applicable to 
the general population.   
Both of the articles in this portion of the literature review focus on IBD patients, but the 
findings can be taken and applied to the general population. Whether abnormal levels of anxiety 
and depression are a result of inflammatory bowel disease itself or simply a secondary byproduct 
of intestinal discomfort, it is clear that there is a connection between gut health and mood.  
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Gut Flora and Mood 
Since it has been established that there is a connection between gut health and mood, it is 
natural to delve further into the gut and question what exactly is acting on the brain. Within the 
gastrointestinal system lives an abundance of bacterial flora that aid with digestion, communicate 
with the immune system, and produce vitamins. In this portion of the literature review, we will 
examine different strains of bacteria found in the gut, and their connection with mood. 
In the beginning of 2019, a Taiwanese study was published with the aim of identifying 
microbiota targets for major depressive disorder and mood-related traits (Chung et al., 2019). 
The researchers recruited thirty-six patients with major depressive disorder (MDD) and thirty-
seven subjects without MDD. Depression, anxiety, and stress symptoms were obtained in the 
initial interview using the Beck Inventories and the Perceived Stress Scale. Then, subjects were 
administered a food questionnaire that contained information about six basic food groups, sugar, 
and diet supplements. From this the researchers were able to analyze the amount of carbs, fats, 
proteins, and fatty acids being consumed by the subjects based on the frequencies in which they 
ate certain foods. Within two weeks of the initial interview, stool samples were collected and 
microbiota DNA was extracted using phenol-chloroform or the QIAamp DNA Stool Mini Kit. 
Although the sample size for this experiment was small, extensive “16S ribosomal RNA gene 
sequencing was conducted” (Chung et al., 2019, p. 76).  
The results of this study reveal multiple targets for depression. This includes four phyla, 
seven families, and twelve genera (Please see Appendix B). At the phylum level, Actinobacteria 
was found in higher prevalence within MDD patients than with controls. Within the family level, 
Streptococcaceae and Bifidobacteriaceae were abundant in patients with MDD while 
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Prevotellaceae was more abundant in the healthy controls. Finally, at the genus level Clostridium 
XI, Parabacteroides, Blautia, and Prevotella were found to be associated with MDD. This was 
along with Holdemania, Eggerthella, Streptococcus, and Sutterella, which the authors note as a 
similar trend from their research.  
The findings from this study are unique and groundbreaking for this topic. Although the 
data was collected from a small study of people in Taiwan who may have different lifestyles and 
dietary habits from people in other parts of the world, the findings are an excellent foundation for 
understanding which bacteria affect major depression.  
 In 2017, a large group of Italian researchers led by Guida performed clinical studies to 
examine the effects of imbalanced microflora on the gut and brains of mice. Their study was 
approved by the Animal Ethics Committee of the Università della Campania of Naples. The 
control group of mice drank water for fourteen days while the test group drank sterile water 
mixed with Ampicillin, Streptomycin, and Clindamycin (ASC). The mice underwent a multitude 
of tests to determine depressive-like behavior, motor coordination, muscle strength, recognition 
memory, working memory, nociceptive pain, and sociability. A Western blot analysis was done 
on brain tissue and samples were collected from each mouse for microbiota analysis and 
inflammatory mediator evaluation. 
Analysis of the data shows that the administration of antibiotics to perturb natural gut 
microbiota leads to “depressive-like behaviour and impaired social activity associated with 
biochemical and functional changes in the hippocampus” (Guida et al., 2017, p. 240). The 
consumption of the ASC mixture created a floral imbalance with a loss of bacterial diversity. 
This increased the presence of Proteobacteria and Actinobacteria in the gut which the authors 
believe led to hippocampal rearrangement and depressive behavior. Although this study was 
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done on mice, this is the first step to understanding how bacteria can be affecting the human 
brain and how this relates to depression. 
In both of the studies mentioned, the findings indicate that the microbiota of subjects 
experiencing depression differ from subjects without depression. Actinobacteria was 
significantly more prevalent in humans with major depressive syndrome as well as mice with 
depressive behaviour. Of course, more research can be conducted in this area, specifically 
targeting Actinobacteria or some of the other bacteria correlated with depression. However, both 
of these studies provide a clear understanding that the intestinal flora of depressed subjects are 
dysbiotic compared to non-depressed subjects. From this information one can now ask: what if 
there was a way to treat this?   
Using Probiotics As Treatment 
The following articles involve trials using probiotic supplements. The use of probiotics is 
growing in popularity as a potential future medical treatment and as a daily health supplement. 
There is still much to learn about different strains of bacteria and what effects each one has on 
the brain. The following articles contain recent experiments attempting to learn more about them. 
Lew and his team conducted randomized, double-blind, placebo-controlled trials using 
Lactobacillus plantarum P8 (2018). The goal of the experiment was to investigate the effects of 
probiotics on the alleviation of stress in stressed adults. Subjects were tested for psychological 
distress using the aforementioned Perceived Stress Scale questionnaire, along with the 
Depression, Anxiety, and Stress Scale (DASS-42), every four weeks. Memory and cognitive 
functions were tested at baseline and at the end of the twelve week study. Blood samples were 
also collected at these times to analyze cortisol, cytokines, and full blood count. 132 subjects 
were originally recruited for the study but only 103 fully complied until the end.  By the end of 
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the study, most of the effects of treatments (P8 and placebo) were insignificantly different from 
one another. However, even though both treatments reduced stress levels from “moderate” at 
baseline to “normal” at week 12; during week 4, 8, and 12 the P8 group had much lower stress 
than the control. Closer analysis of the DASS-42 over this time period attributes this to reduction 
of “touchiness”, reduced irritation, increased calmness, and increased tolerance against 
interruptions. This goes to show that L. plantarum P8 may have a potential future as an 
anxiolytic supplement. 
In Stress matters: Randomized controlled trial on the effect of probiotics on 
neurocognition, the team set out to investigate the effects of a multispecies probiotic on the 
neurocognitive measures of emotion (Papalini et al., 2019). They wanted to test whether 
probiotics could be used to buffer against the effects of stress on memory. This was a 
randomized, double blind, placebo-controlled trial that utilized fifty-eight healthy patients. Each 
participant was assessed before treatment and again four weeks later. During these assessments 
they performed a working memory test and received an MRI measurement. Some of the tests 
included the emotional face-matching paradigm which tested for emotional reactivity by 
choosing words to match pictures of faces, the color-word stroop paradigm where subjects were 
to choose the color of the word ink while ignoring what the word says, and the digit span test 
where subjects had to repeat numbers forwards or backwards. During the four week period 
subjects were instructed to take the probiotic every day. 
The results of the questionnaires and MRIs did not appear to be different between the 
probiotic and placebo group. There was, however, a difference in stress-induced working 
memory between the groups as the probiotic groups had increased performance on their second 
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stress-induced backward digit span performance. These results indicated that the group taking 
probiotics had developed a larger buffer against the negative effects of stress on their memory. 
Pinto Sanchez and her team conducted research on the probiotic Bifidobacterium longum 
NCC3001 to evaluate its effects on anxiety and depression for patients with irritable bowel 
syndrome (2017). This study was mentioned multiple times throughout other research and was 
used as a guiding framework for other probiotic studies.  Data was collected from forty-four IBS 
patients at baseline, six weeks, and ten weeks. To qualify, the subjects needed a diagnosis of 
IBS, needed to be experiencing diarrhea or mixed-stool patterns, and had to have anxiety and/or 
depression. Anxiety and depression were analyzed by the Hospital Anxiety and Depression 
Scale. Blood, stool, and urine samples were collected to test for inflammatory markers and 
microbiota profiles. MRIs were used to assess brain activity.  
After six weeks, the patients in the B. longum group had decreased depression scores 
compared to the placebo group. There was no changes found for patients with anxiety. 
Sensitivity analysis was used to understand the relationship between B. longum and depression 
and the theme was that lower depression was more likely to occur with those who felt adequate 
relief from IBS symptoms. MRIs showed that the probiotic group showed reduced engagement 
in the amygdala, frontal, and temporal cortices in response to fear stimuli. There was also 
heightened engagement of the occipital regions in response to fear. With these results, the 
authors drew the conclusion that Bifidobacterium longum NCC3001 decreased depression 
scores, but not anxiety scores. They go on to discuss how depression and anxiety are related to 
amygdala hyperactivity but both SSRIs and B. longum were able to benefit the patient by 
decreasing its activity. This goes to show how probiotics may be able to take a stand in the world 
of antidepressants. 
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The final article to be reviewed is Effect of Lactobacillus rhamnosus HN001 in 
Pregnancy on Postpartum Symptoms of Depression and Anxiety: A Randomised Double-blind 
Placebo-controlled Trial (Slykerman et al., 2017). These trials were conducted in order to 
evaluate the effect of the bacteria Lactobacillus rhamnosus HN001 when administered during 
pregnancy. The team specifically wanted to evaluate the effects of the bacteria on maternal 
anxiety and depression during the postpartum time period. This study received approval from the 
New Zealand Multi Regional Ethics Committee and was deemed safe for pregnancy. 423 women 
were recruited for this study and were randomly split into a HN001 group and a placebo group. 
The mothers were interviewed at 14-16 weeks gestation as their baseline. They received the 
probiotic or placebo from the initial interview all the way until six months postpartum if 
breastfeeding. The Edinburgh Postnatal Depression Scale and State Trait Anxiety Inventory (6 
item) were used to help mothers describe their psychological wellbeing from when their child 
was one to two months old. This was done at six or twelve months postpartum. 
At the trials’ conclusion, 380 participants completed the study. Eleven of the mothers 
completed the questionnaires at the six month visit and 112 completed them at the twelve month 
visit. Mothers who received probiotic treatment reported significantly lower depression and 
anxiety scores than the placebo group. These scores tended to increase the longer that the mother 
took to complete the questionnaire. The researchers believe that this is because many mothers 
expect to be tired during their first year of motherhood and do not realize that they may be 
depressed. It may be hindsight that allows the mothers to realize how depressed and anxious they 
were feeling in the first two months postpartum. The number of women who reported clinically 
significant depression above the standard cut-off point did not differ between the HN001 group 
and the placebo group. However, women receiving the HN001 treatment were significantly less 
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likely to have anxiety above the cut-off point. This study is one of the first of its kind as it studies 
the effects of probiotics on pregnant women and postpartum depression. This study could have 
been more accurate if they had collected questionnaire data from mothers all at the same time, or 
if they administered the questionnaires to each mother twice. This study has great implications 
for treatment of postpartum depression and the future of antidepressants. 
Literature Review Conclusion 
 Satisfactory evidence was found on the primary question of interest, “does the use of 
probiotic supplementation have an effect on feelings of depression?” According to the research, 
the use of different probiotics can have multiple different effects on feelings of depression 
including relief of stress, increased calmness, reduced irritation, improved working memory 
under stress, and reduced amygdala activity. In addition, certain strains of probiotics also have an 
effect on anxiety and possibly IBD flare ups. Lactobacillus plantarum P8, Bifidobacterium 
longum NCC300, and Lactobacillus rhamnosus HN001 are three specific probiotic strains that 
have demonstrated effects on depression and anxiety. 
 The greatest limitation that I have found within the studies is the small sample size within 
all except Kappelman and Lew’s studies. Data is not as reliable within such small samples, but 
because this research is so new it is an acceptable framework. All of the data collected from each 
team was located within a specific geographic radius. This can be considered a limitation 
because the dietary habits and lifestyle elements of different regions can have an effect on the 
microbiota that form in their subject’s studies. This is a consideration to keep in mind while 
forming future experiments and studies if one is hoping to focus in on a certain group of people. 
 Although this research is paving a new route for medical treatments, I do not believe it is 
worthy of guiding standard practice quite yet. With the introduction of new bacteria to people’s 
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bodies can come new risks and adverse effects. While many practitioners may agree that 
probiotics are a safe dietary supplement, more research needs to be done before it can be 
recommended as an alternative to SSRIs. There is no proof that probiotics can cure depression or 
that they work better than traditional antidepressants, but it may be worthy of mentioning for 
patients newly diagnosed with depression. Or even to neurotypical people who may be feeling 
some of “the blues.” I believe the research is worthy of guiding future experiments on the topic. 
A gap that I have identified within this research is more specified trials to determine 
which probiotic strain would be the absolute best for decreasing depression. This gap is not 
surprising considering how novel the topic is, and within the next decade there are bound to be 
many more studies revealing which probiotics work the best. 
Proposal for Further Study 
The gap that I have identified within my research are a lack of studies specifically on the 
probiotics that have been identified for having effects on depression. By doing further studies on 
these probiotics, such as Lactobacillus plantarum P8, Bifidobacterium longum NCC300, and 
Lactobacillus rhamnosus HN001, we can determine whether certain strains can be used as 
antidepressant therapy. The research study that I would like to propose is a double-blind, 
randomized, placebo-controlled clinical trial comparing the effects of specific probiotics on 
feelings of depression. The primary research question is: Which probiotic decreases symptoms of 
depression in the fastest and most significant way - Bifidobacterium longum NCC300, 
Lactobacillus plantarum P8, or both?  
As stated in the review of literature, Bifidobacterium longum NCC300 was correlated 
with decreased depression. This may be linked to the fact that the probiotic decreases amygdala 
activity, which controls the autonomic nervous system and feelings of fear. Selective serotonin 
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reuptake inhibitors (SSRIs) are similar to NCC300 in this way. This could imply that higher 
doses of NCC300, or doses of NCC300 combined with other elements, could be a competitor 
with SSRIs for the treatment of depression. In the study by Lew, Lactobacillus plantarum P8 
was not being specifically tested for its effect on depression, but it was correlated with “the 
alleviation of selected stress, anxiety, memory and cognitive symptoms in stressed adults” 
(2018). All of these factors play a role in clinical depression, so it is not unreasonable to 
hypothesize that P8 could have antidepressive effects. For this proposed study, research should 
be conducted to determine the efficacy of specific, commonly-used SSRIs. Standardized scales 
should be identified so the efficacy of NCC300 and P8 can be compared. By doing this, these 
probiotics and SSRIs can be compared to see whether they have similar effects on the feelings of 
depression. 
The primary aim of this quantitative research is to investigate the effects of 
Bifidobacterium longum NCC300, Lactobacillus plantarum P8, and the two combined on 
feelings of depression. Another aim of this study is to compare data collected about the efficacy 
of NCC300 and P8 as antidepressants with the efficacy of commonly used SSRIs such as Celexa, 
Lexapro, Prozac, and Zoloft.  
This study would absolutely be cleared by an institutional review board to ensure that 
subjects are protected from harm. The Dominican University of California has an Institutional 
Review Board that would be able to do this, but due to the nature of the experiment, extra 
institutional reviews would be beneficial. With the use of human subjects there is always a risk 
of bringing harm to the subject. Because this study involves the supplementation of bacteria, 
extra precautions and screening must occur to ensure that no adverse reactions will come to the 
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patient, especially those with comorbidities. Before taking any part in the study, all subjects will 
need to be educated on what the study will entail and sign a consent form to participate. 
The population of this study will be patients age 18-65 who have been diagnosed with 
depression. Inclusion criteria will be a diagnosis of depression without any current 
pharmaceutical treatments for mental health and the ability to carry out the full experiment. 
Exclusion criteria would include current SSRI treatment, current antibiotic therapy, recreational 
drug use, body mass index that is severely out of the healthy range, severe medical illnesses, or 
mental illness that interferes with the subject’s ability to participate or understand the study. For 
this particular study, purposive sampling can be used and subjects can be recruited through 
psychologists, therapists, and psychiatrists offices. By doing this, we would be finding 
participants who fit the specific criteria without having to sort through and screen every applicant 
for their mental health history. From here, the applicants who have passed the screening can be 
randomized. My proposed sample size would be at least 500 participants. This sample size was 
chosen to account for people dropping out of the study with the intention of having at least 100 
participants in the placebo-controlled group, 100 in the Bifidobacterium longum NCC300 group, 
100 in the Lactobacillus plantarum P8 group, and 100 in the combination group. Subjects would 
be randomized after the screening and assigned different identification numbers every time they 
were assessed. 
After screening is done and consent is obtained, the initial baseline interview should be 
conducted. This should include the subjects’ demographics, diagnoses, current medications, and 
feelings of anxiety and depression based on the DASS-42 and BDI-II. The Depression, Anxiety 
and Stress Scale (DASS-42) uses a 42 item questionnaire comprised of three sub-scales. Each 
scale contains 14 items that assess symptoms such as dysphoria, hopelessness, self-deprecation, 
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loss of interests, autonomic arousal, subjective experiences of anxiety, relaxing difficulties, 
irritability, and impatience. This standardized scale is a useful tool because it is used in other 
health care settings and controls have been established. For the purposes of this experiment, it 
will be easier to compare subjects’ results with the results from other studies. Although the focus 
of the study is depression, it is not uncommon to find that stress, depression, and anxiety go hand 
in hand and influence one another. Using the DASS-42 provides holistic information about the 
subjects’ depression and mental state. The Beck Depression Inventory II is a standardized scale 
that measures severity of depressive by allowing subjects to rate their feelings on a 1-4 scale 
depending on severity (Please see Appendix C). This includes feelings of sadness, guilt, 
hopelessness, anhedonia, suicide, crying, agitation, loss of appetite, and more. By using this 
second questionnaire we can analyze more specified data regarding depression. 
 Once the initial interview has been conducted, subjects should receive random numbers 
assigning them to the control group, the Bifidobacterium longum NCC300 group, the 
Lactobacillus plantarum P8 group, or the combination group. Instructions should be given on 
how and when to ingest the probiotic. Subjects should be instructed to ingest the probiotic 
powder at approximately the same time every morning. The two questionnaires should be 
repeated after six weeks and again after twelve weeks. By doing this, there should be enough 
longitudinal data to be able to identify trends and a comparative analysis. 
 In order to analyze the data from the four groups; NCC300, P8, combination, and 
placebo; a one-way analysis of variance (ANOVA) should be performed. This form of analysis 
can be used to determine whether there are statistically significant differences between the four 
groups. Following this analysis, depression scores can be compared and contrasted with one 
another along with previous data collected about SSRIs.  
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Theoretical Framework 
This framework for my proposed study comes from evidence-based physiology. Studies 
have demonstrated that there is a brain-gut pathway that is affected by the flora within the 
gastrointestinal system. Clinical trials concluded that a change in the microbiota of the gut could 
lead to alterations in mood such as “depressive-like behaviour and impaired social activity 
associated with biochemical and functional changes in the hippocampus” (Guida et al., 2017, p. 
240). Studies conducted specifically about probiotic supplements have indicated a correlation 
between probiotics and decreased feelings of depression, anxiety, stress, and related symptoms. 
By understanding the quantitative data behind these studies we are able to delve deeper into 
these probiotics to find whether or not they can be used as antidepressant treatment. Without the 
research that preceded this proposal, there would not be a reason to suspect that probiotics would 
have anything to do with clinical depression. 
Conclusion 
 Throughout the research, satisfactory evidence was found and the primary question of 
interest, “does the use of probiotic supplementation have an effect on feelings of depression?”  
was answered. Probiotics work on the human body when they are digested, releasing chemicals 
that are absorbed in the gastrointestinal tracts and work on the human brain. The effects of these 
bacteria can include relief of depressive symptoms along with relief from stress and anxiety. 
Lactobacillus plantarum P8, Bifidobacterium longum NCC300, and Lactobacillus rhamnosus 
HN001 are three specific probiotic strains that have demonstrated effects on depression and 
anxiety. Findings show that different probiotics have different effects on the mind, which is why 
much more research should be done on this topic.  
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 Using this information, health care professionals can develop new ways of treating 
depression and anxiety. When a patient is newly diagnosed with depression, the use of therapy 
and probiotics could be the first plan of treatment before switching to pharmaceutical drugs like 
selective serotonin reuptake inhibitors. Or perhaps probiotics will be so well-studied that they  
become the more natural solution to mental health crises and replace pharmaceuticals as the 
standard of care altogether.  
My proposed research should be one of the first stepping stones in learning whether 
probiotics can be used as antidepressants. Before probiotics can be considered as a formal 
treatment, much more research needs to be done to explore which bacteria have a negative effect 
on depression. Researchers need to narrow down on which strains are the most beneficial for 
treatment and do titration studies to determine the best dosage for patients. My study will help to 
narrow down and evaluate whether Bifidobacterium longum NCC300, Lactobacillus plantarum 
P8, or a combination of these would even be a consideration for further studies. From there, 
these will need to be evaluated for adverse effects, contraindications, and any drug interactions. 
With time, and more research, there is much hope for the future of probiotics and the treatment 
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